PJ

Pankaj Jaiprakash Rathi

Active Director Director DIN 10615430
DIN 10615430 First appointment May 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Pankaj Jaiprakash Rathi

Data last updated:

Pankaj Jaiprakash Rathi is a Director at Hridayu Medtech Private Limited (since 2024).

DIN 10615430
Primary Designation Director
First Appointment 03 May 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hridayu Medtech Private Limited U32509PN2024PTC230641
Director03 May 20242024Active

Board colleagues of Pankaj Jaiprakash Rathi

NameDINCompanyDesignation
Preeti Chaudhary10615431Hridayu Medtech Private LimitedNon- Individual Subscriber
Shveta Dang09218154Hridayu Medtech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Hridayu Medtech Private Limited
Premium access

Shareholding and investment profile for Pankaj Jaiprakash Rathi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pankaj Jaiprakash Rathi

Pankaj Jaiprakash Rathi currently holds 1 directorship: Hridayu Medtech Private Limited (Director, since 03 May 2024).

Pankaj Jaiprakash Rathi was first appointed on 03 May 2024 as Director at Hridayu Medtech Private Limited.

The current boards of Pankaj Jaiprakash Rathi's companies include Preeti Chaudhary (Hridayu Medtech Private Limited), Shveta Dang (Hridayu Medtech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available